Advertisement
U.S. markets closed

Sol-Gel Technologies Ltd. (SLGL)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
0.5340+0.0500 (+10.33%)
At close: 04:00PM EST
0.5151 -0.02 (-3.54%)
After hours: 07:36PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.4840
Open0.5089
Bid0.0000 x 0
Ask0.5500 x 100
Day's Range0.4755 - 0.6769
52 Week Range0.3340 - 1.5750
Volume268,796
Avg. Volume78,590
Market Cap14.876M
Beta (5Y Monthly)1.60
PE Ratio (TTM)N/A
EPS (TTM)-0.3400
Earnings DateNov 15, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.00
  • Zacks

    SolGel Technologies (SLGL) Upgraded to Buy: Here's What You Should Know

    SolGel Technologies (SLGL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

  • GlobeNewswire

    Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement

    NESS ZIONA, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with severe skin conditions, conducting a Phase 3 clinical trial of SGT-610 (patidegib gel, 2%) for Gorlin syndrome, and with two approved large-category dermatology products, TWYNEO® and EPSOLAY®, today announced that it has received an extension of the period to regain compliance with The Nasdaq Stock Market LLC’s ("Nasdaq") minimum bid pric